baber/WOPTO huggingface dataset:
Patent NZ-192515-A (NZ)
Title: Detonator with resistive fusehead and control circuit incorporating shunt and series inductors
Inventor: JONES E
IPC: F42B3/18
Filed: 1980-01-04
Abstract: A control circuit for firing an electrically actuable igniter (11) in response to a firing signal having predetermined characteristics. For protection from inadvertent or accidental actuation, the control circuit includes at least one inductor in series (14) with the fuse wire of the igniter and at least one inductor in parallel (16) with the source of the firing signal. The series and parallel inductors are electromagnetically coupled to one another through a ferrite bead (20) and are electrically connected so as to generate opposed magnetic effects when current flows through them. Electric detonators incorporating the control circuit are also detailed.
Patent NZ-208109-A (NZ)
Title: Slide casting of hollow concrete slabs
Inventor: BARSK J O
IPC: B28B1/08
Filed: 1984-05-09
Abstract: Method and slide-casting machine for the casting of hollow slabs out of concrete by slidecasting. Concrete mix is extruded onto a base (18) preferably by means of a conical screw spiral (2). Thereinafter the mix is compacted by moving a cavity mandrel (3) fitted after the screw spiral. The end of the cavity mandrel (3) is moved along a path of movement of desired shape. The final end of the mandrel may be attached to the machine by means of a ball joint.
Patent NZ-210453-A (NZ)
Title: Blister pack for divisible tablets with sealable compartment for divided tablet portion
Inventor: PERTHES D
IPC: B65D75/34
Filed: 1984-12-06
Abstract: 1. A blister package for divisible tablets, in which the tablets lie individually in the depression of a film, which are covered by another film, it being possible to remove the tablets individually by pressing them through this sealing film, wherein the package has a single cover (7) with which an opened depression (2) can be sealed.
Patent NZ-216218-A (NZ)
Title: Holder for animal carcasses being boned or carved: device applied internally
Inventor: VILLEMIN D
IPC: A22C21/00
Filed: 1986-05-19
Abstract: An apparatus for holding a gutted animal body having an empty body cavity that has an open end and a closed end has an elongated holder body having a front portion and a rear portion offset along a longitudinal axis of the holder body from the front portion. The portions are interconnected for relative axial displacement between an adjacent position and an axially extended position. A holder is provided on the front portion for engaging same in the closed end and another holder is provided on the rear portion for engaging same adjacent the open end when the holder of the front portion is engaged with the closed end. The system is operated such that, on engagement of the holder body in the body cavity with the portions in the adjacent position, the rear holder is engaged with the animal body adjacent the respective end, the front and rear portions are axially extended away from each other, and then the front holder is engaged with the respective cavity end.
Patent NZ-237326-A (NZ)
Title: Electrochemical protection in water: depletion of zinc coating prevented
Inventor: RIFFE WILLIAM J
IPC: C09D5/10
Filed: 1991-03-05
Abstract: 2083263 9118130 PCTABS00008 A device and method for preventing fouling and/or corrosion of the exposed surfaces of a structure which is in contact with seawater, brackish water, fresh water, or a combination of these. The system includes using a structure (10) having an exposed zinc-containing surface (16). At the exposed surface water interface a negative capacitive charge or an asymmetric alternating electrostatic is induced and maintained.
Patent NZ-237379-A (NZ)
Title: Substituted urea derivatives and pharmaceutical compositions
Inventor: BOURZAT JEAN-DOMINIQUE
IPC: A61P25/00
Filed: 1991-03-11
Abstract: PCT No. PCT/FR91/00195 Sec. 371 Date Sep. 11, 1992 Sec. 102(e) Date Sep. 11, 1992 PCT Filed Mar. 11, 1991 PCT Pub. No. WO91/13862 PCT Pub. Date Sep. 19, 1991.Compounds of formula:    <IMAGE>  (I)  in which R1 represents an alkyl radical, R2 represents a phenyl radical or a chain -(CH2)m-R4 in which m is equal to 0, 1 or 2 and R, represents a hydroxyl, alkoxy or amino radical, R3 represents a hydrogen atom or an alkyl, alkoxy or alkylthio radical and n is equal to 0 or 1, their preparation and medicinal products containing them.
Patent NZ-237689-A (NZ)
Title: Pyridine derivatives and medicaments
Inventor: MILLS STUART DENNETT
IPC: A61K31/44
Filed: 1991-04-04
Abstract: This invention concerns novel aminopyridinium compounds of the formula I wherein R<1>, R<2>, R<3>, R<5> and R<6> are selected from the following combinations: <CHEM>     (a) one of R<2> and R<6> is a basic group selected from amino, alkylamino, dialkylamino of up to eight carbon atoms, pyrrolidino, piperidino and morpholino, or is alkyl, alkenyl, alkoxyalkyl, alkoxy, alkylthio, phenyl, phenylalkyl, cycloalkyl or cycloalkylalkyl; and the other of R<2> and R<6> is hydrogen, alkyl or one of the above defined basic groups; R<1> is alkyl, alkenyl, cycloalkyl, phenyl, phenylalkyl, cycloalkylalkyl; and R<3> and R<5> are independently hydrogen, alkyl or alkenyl; (b) R<2> is a basic group as defined above, R<5> and R<6> together form alkylene or, together with the appendant carbon atoms of the pyridine ring, complete a benzene ring; R<1> has any of the meanings defined in (a) above; and R<3> is hydrogen, alkyl or alkenyl; and (c) R2 has any of the meanings defined above and R<6> is a group of the formula -NR<7>.A- in which A together with R<1> forms an ethylene, trimethylene or tetramethylene link and R<7> is hydrogen or alkyl; and R<3> and R<5> have, independently, any of the meanings defined in (a) above; and wherein R<4> is hydrogen, cycloalkylalkyl, alkyl, alkenyl, alkynyl or phenylalkyl; and Q is phenyl; or the group Q.N(R<4>)- together constitutes an azaheterocyclic moietyo; Y is a physiologically acceptable anion; and any one or more of said phenyl or benzene moieties may optionally be unsubstituted or bear one or more selected substituents.   The invention also includes certain closely related anhydro-base derivatives which, like the formula I componds, possess beneficial effects on the cardiovascular system. Also included are pharmaceutical compositions and processes for the manufacture of the various novel compounds.
Patent NZ-239403-A (NZ)
Title: Antioxidant compositions - extracted from leaves-containing 2'-o-glucosyl isovitexin
Inventor: YOSHIHIDE HAGIWARA
IPC: A23L7/109
Filed: 1991-08-15
Abstract: An antioxidant substance which is derivable from green leaves of a green plant, comprising a component which is soluble in water or substantially insoluble in n-hexane, and soluble in an aqueous ethanol solution having a water content of 0 to 80% by volume. The substance has an antioxidant activity at least as potent as  alpha -tocopherol, and is useful as an antioxidant for use in the field of foods, and medicines. Particularly, the antioxidant substance can be used to maintain the freshness and quality of foods or storage thereof. The substance can be blended with cosmetics for skin and hair and used for the prevention of spots, freckles, chapping and sunburning.
Patent NZ-239524-A (NZ)
Title: Preparation of hydroxyamides
Inventor: SCHLAEFER FRANCIS WILLIAM
IPC: C07C233/18
Filed: 1991-08-23
Abstract: A method of preparing solid hydroxyalkylamides by reacting carboxylic alkyl esters with alkanolamines at controlled reaction temperatures, removing the alcohol byproduct, controlling the temperature of the reaction mixture to form a slurry, maintaining the slurry and recovering the solid hydroxyalkylamides.
Patent NZ-252801-A (NZ)
Title: Minimizing interference during initiation of access between mobile and base radio station
Inventor: DENT PAUL W
IPC: H04B7/005
Filed: 1993-04-08
Abstract: The present invention includes a system and method for minimizing interference between two radio stations, e.g., a mobile radio telephone and a fixed base station, at the initiation of a radio communication. A mobile station initiates a random access at the lowest power level and increases the transmission power level until the base station detects the access signal. Once detected, the power level of the message is maintained at the detected level so that the signal interference is avoided. The present invention also provides a mechanism for synchronizing random access communications between mobile stations and the base station despite variation in distances between the mobile and base stations.
Patent NZ-280744-A (NZ)
Title: Treatment of hypothalamic amenorrhea in non-depressed female mammals by administering an hydroxycycloalkanephenethylamine derivative
Inventor: UPTON GERTRUDE VIRGINIA
IPC: A61K31/137
Filed: 1995-12-21
Abstract: The specification describes the treatment of hypothalamic amenorrhea in a non-depressed female mammal by administering to the mammal an effective amount of a hydroxycycloalkanephenethyl amine compound of structural formula (I): in which A is a moiety of the formula (II) wherein the dotted line represents optional unsaturation; R1 is hydrogen or C1-6 alkyl; R2 is C1-6 alkyl; R4 is hydrogen, C1-6alkyl, formyl, or C2-7 alkanol; R5 and R6 are, independently, hydrogen, hydroxyl, C1-6 alkyl, C1-6 alkoxy,                        C2-7 alkanoyloxy, cyano, nitro, C1-6 alkylmercapto, amino, C1-6 alkylamino,                     C1-6 dialkylamino, C1-6 alkanamido, halo, trifluoromethyl, or taken together, methylene dioxy; R7 is hydrogen or C1-6 alkyl; and n is 0, 1, 2, 3, or 4; or a pharmaceutically acceptable salt thereof. A preferred compound is 1-[(2-dimethylamino)-1-(4-methoxyphenyl)ethyl]cyclohexanol.
Patent NZ-332744-A (NZ)
Title: Phosphonic acid-substituted benzazepinone-n-acetic acid derivatives processes for their use in the preparation of medicaments
Inventor: WALDECK HARALD
IPC: A61K38/05
Filed: 1998-11-11
Abstract: A compound of formula I, a process for its preparation and use of the compound in the manufacture of a medicament useful in the treatment of cardiac insufficiency and high blood pressure. R1 and R2 are independently hydrogen or a group forming a biolabile phosphonic acid ester and R3 is hydrogen or a group forming a biolabile carboxylic acid ester.
Patent NZ-333601-A (NZ)
Title: Synchronous compensator plant with layered semiconductive insulation of machine windings
Inventor: LEIJON MATS
IPC: H01F27/00
Filed: 1997-05-27
Abstract: A synchronous compensator plant includes a rotating electric machine 1.  The windings 5 in the machine operate at high voltage (36kV) and are of a cable having an insulation system including at least two semiconducting layers 32, 34 which each constitute an equipotential surface, separated by a solid insulation layer 33.
Patent NZ-333737-A (NZ)
Title: Parenteral formulations of taxane analogs comprising dimethylacetamide, polyethylene glycol and an aqueous lipid emulsion
Inventor: ANDERSSON BORJE S
IPC: A61P33/00
Filed: 1997-06-26
Abstract: Disclosed is a stable and effective formulation of a taxane analog, preferably paclitaxel.  The formulation comprises a dimethylacetamide and polyethylene glycol solution of the drug that is diluted into an aqueous lipid emulsion prior to use. The formulation is effective as a parenteral drug against taxane sensitive tumors.
Patent NZ-500197-A (NZ)
Title: Dimensionally stable tufted carpet having a double primary backing
Inventor: IRWIN DONALD A
IPC: B32B5/26
Filed: 1998-04-29
Abstract: Provided is tufted (11) carpet (10) with a two-part primary backing (12) and without application of a secondary backing.  The upper, or face, backing (14) is a conventional woven or non-woven polypropylene, and the lower, or back, backing (15) is a stronger, less stretchable than the first backing, open weave fabric.  First backing (14) and second backing (15) are contiguous with each other, with the first backing forming a first side of primary backing (12) and second backing (15) forming an opposite side of the primary backing.  The tufts of yarn (11) are sewn through both parts of primary backing (12), which holds the parts (14, 15) together, and causes some of the back stitches to protrude for better coating with adhesive and forms a plurality of back stitches on the opposite side of primary backing (12) wherein at least a major portion of the back stitches secure first backing (14) to second backing (15).  The resulting carpet may be fully back coated, and may have a secondary backing adhered thereto.  The lower backing prevents elongation, stretching and shrinking of the carpet during manufacture and subsequent processing.
Patent NZ-503159-A (NZ)
Title: Improvements in or relating to the preparation of lactam compounds
Inventor: NICOLA MAZIN
IPC: C12P13/00
Filed: 1998-09-03
Abstract: A method of preparing a second compound by catalytic conversion of a first compound is described.  The method comprises contacting the first compound and a catalyst in a solvent mixture comprising water and a first non-aqueous solvent.  The first non-aqueous solvent is a non-chlorinated, fluorinated alkene or alkyne having four or fewer carbon atoms and the catalyst is an enzyme.
Patent NZ-504005-A (NZ)
Title: Composition comprising white petrolatum, cayenne pepper, chilli powder and denatonium benzoate effective as a chewing deterent
Inventor: HAWTHORNE NORMAN VICTOR
IPC: A01N37/18
Filed: 2000-04-17
Abstract: A composition that can be applied to surfaces and animal tails to prevent chewing of said surfaces and tails.  The composition comprises petrolatum, cayenne pepper, chilli powder and denatonium benzoate NF.  The composition ay be liquefied by heating to allow application by means of a brush or rag.
Patent NZ-504200-A (NZ)
Title: Pesticides comprising alpha, beta-unsaturated ketone compounds
Inventor: HODGKINSON LESLIE CHARLES
IPC: A01N43/10
Filed: 2000-04-27
Abstract: 2-cyclohexenone, 5-pheny;-3-formyl-pyran-4-one and compounds of formula (I) are useful as pesticides, particularly against Psoroptes cuniculi, Psoroptes ovis and Musca domestica. In formula (I), R1 is a phenyl group optionally substituted with one or two chlorine atoms, a naphthyl group or a furyl group optionally substituted by one or two methyl groups and R2 is a group selected from phenyl, furyl, thienyl, furfuryl, thieb-2-ylmethyl or 1,3-benzodioxole. Compounds of formula (I), wherein R1 is 2-naphthyl and R2 is furfuryl; or R1 is phenyl and R2 is fur-3-yl; or R1 is fur-3-yl and R2 is 2,5-dimethylfur-3-yl; or R1 is phenyl and R2 is 3,4methylenedioxyphenyl, are claimed.
Patent NZ-508007-A (NZ)
Title: Compounds for the treatment of female sexual dysfunction that potentiate cAMP activity and is an inhibitor of neuropeptide-Y (NPY)
Inventor: MAW GRAHAM NIGEL
IPC: A61K38/55
Filed: 2000-11-07
Abstract: A pharmaceutical composition and a method of treatment of female sexual dysfunction (FSD), in particular female sexual arousal disorder (FSAD). Also described is a method of screening compounds useful in the treatment of FSD, in particular FSAD. The preferred embodiment describes the use of a neuropeptide-Y (NPY) inhibitor.
Patent NZ-510044-A (NZ)
Title: Apparatus for detecting markings on opposite end faces of a wood block for centering for veneer forming, by pairs of lenses of differing focal length
Inventor: KOIKE MASARU
IPC: B27L5/02
Filed: 2001-02-19
Abstract: In order to overcome prior art errors in locating wood blocks to be located in a veneer lathe, two pairs of imaging devices (typically CCD cameras) 45, 49, and 47,51 are provided with associated image processing apparatus. The imaging devices have different focal lengths relating to each pair. This is stated to allow for accurate placement of movable supports 23, 25.
Patent NZ-510680-A (NZ)
Title: Process for controlling maillard-type glycation of whey proteins and products with enhanced functional properties
Inventor: HAGGARTY NEILL WARD
IPC: A23C21/08
Filed: 1999-09-28
Abstract: A method of storing whey protein-containing dry powdered material comprising the steps; i) Predetermining the initial level of glycation of the whey protein-containing dry powdered material; and either ii) increasing the glycation level of the whey protein-containing dry material of step i) by subjecting the material to Maillard-type glycation reaction by storing the whey-protein containing dry powdered material under controlled temperature and moisture conditions for a sufficient time to produce a desired level of glycation without causing denaturation of the whey protein, followed by termination of the Maillard-type reaction after a desired level of glycation has been reached by storing the whey protein-containing dry powdered material under controlled temperature and moisture conditions which inhibit the glycation reaction; or iii) inhibiting further glycation of the whey protein-containing dry powdered material of step i) by storing the material under controlled temperature and moisture conditions to inhibit the glycation reaction.
Patent NZ-511448-A (NZ)
Title: A dosage form of diltiazem that exhibits a release rate profile corresponding to a "two peak" plasma level profile in vivo
Inventor: CHENG XIU XIU
IPC: A61K9/50
Filed: 1999-11-01
Abstract: A once-a-day controlled release formulation of a water soluble drug is described which includes: (a) from 20% to 50% by weight of enteric polymeric membrane coated pellets comprising a polymer membrane coated core which comprises a biologically inert core which is coated with a first layer which consists of a water soluble drug and a binder; and a second layer which comprises a membrane comprising a pH dependent polymeric material; and (b) from 50% to 80% by weight of delayed pulse polymeric membrane coated pellets comprising a polymeric membrane coated core which comprises a biologically inert core which is coated with a first layer which consists essentially of a water soluble drug and a binder and a second layer which comprises a polymeric membrane and a alkaline earth metal stearate which will substantially maintain its integrity in the varying pH conditions of the gastrointestinal tract but is permeable to said water soluble drug; and (c) a unit dose containment system.
Patent NZ-513652-A (NZ)
Title: Process for extracting fixed and mineral oils
Inventor: WILDE PETER FREDERICK
IPC: C11B9/02
Filed: 2000-01-20
Abstract: The present invention relates to a method of extracting and concentrating oils from materials in which the oils are already dispersed. More particularly, the present invention is concerned with the extraction of fixed oils or mineral oils from materials using a process of solvent extraction which is performed under elevated pressure and temperature. The solvent medium may be HFC 134a alone, or HFC 134a in combination with a suitable co-solvent which can be determined in accordance with the invention.
Patent NZ-514022-A (NZ)
Title: Methods and apparatus for authenticating the download of information onto a smart card
Inventor: PETIT FREDERIC
IPC: H04W12/02
Filed: 2000-03-10
Abstract: Systems and methods for producing a digitally-computed acknowledgement   of   a  delegated   download   event.   An information  owner,  such as the issuer  of  a  smart  card, delegates  information  download  to  a  third  party.   The information  is  downloaded  from  the  third  party  to  an information  device,  such  as a smart  card.  The  computed acknowledgement is a digital "seal" or signature  (depending upon the type of cryptographic algorithm used). The seal  or signature  is preferably  a  cryptogram  generated  by  the information device using cryptographic keys resident on  the information  device itself. This  acknowledgement  is  then made  available to the information owner, who may then  test the   cryptogram  to  determine whether  the  third   party successfully completed the software download.
Patent NZ-515140-A (NZ)
Title: Conformationally restricted polyamine analogs as disease therapies for cancer, epilepsy, alzheimers, infections, grafts and others
Inventor: FRYDMAN BENJAMIN
IPC: A61P25/08
Filed: 2000-04-27
Abstract: A conformationally restricted polyamine analog of the formula: E-NH-B-A-B-NH-B-A-B-NH-B-A-B-NH-B-A-B-NH-E wherein: each A is independently selected from the group consisting of a single bond, Cl-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, C3-C6 cycloaryl, and C3-C6 cycloalkenyl; each B is independently selected from the group consisting of a single bond, C-C6 alkyl, and C2-C6 alkenyl; and each E is independently selected from the group consisting of H, Cl-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, C3-C6 cycloaryl, and C3-C6 cycloalkenyl; with the proviso that either at least one A moiety is selected from the group consisting of C2-C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, C3-C6 cycloaryl, and C3-C6 cycloalkenyl, or at least one B moiety is selected from the group consisting of C2-C6 alkenyl; and any salt or stereoisomer thereof. Such Compounds are useful in the treatment of diseases such as cancer and other diseases associated with cell proliferation, Alzheimer's disease, epilepsy, multiple sclerosis, problems associated with tissue grafts and organ transplants, psoriasis, restenosis, stomach ulcers, or tissue overgrowth after surgery, or an infection or infestation of parasites, bacteria, fungi or insects.
Patent NZ-517251-A (NZ)
Title: Process to make a sustained release formulation
Inventor: LOUGHMAN THOMAS CIARAN
IPC: A61K47/48
Filed: 2000-08-14
Abstract: A process for preparing compound (I) where compound (I) comprises compound (A) and is ionically bound to a polymer of lactide units, glycolide units and tartaric acid units in ratio of 71-73%:26-28%:1-3% via a carboxylic group of said polymer, said process comprising reacting in a mixture of acetonitrile and water (3:1 weight ratio), at a temperature of 0-5°C, an aqueous solution of compound A with the polymer.     NZ Patent Office Journal 1490 published on 29 August 2003 - Part 4
Patent NZ-525426-A (NZ)
Title: System and method of attracting and lodging PCT national phase applications
Inventor: SIMPSON JUSTIN RYAN
IPC: G06Q50/18
Filed: 2001-10-23
Abstract: A computer based system is for attracting and then lodging a PCT national phase patent application with the appropriate patent office. The computer system interface (170) for lodging a PCT national phase application with a patent office is adapted to receive a national phase filing instruction that identifies a PCT application and a nominated prosecuting attorney firm. The interface is in communication with a document generator (171) that is adapted to generate a national phase entry message and an instructing message to the prosecuting attorney firm. The generator is in communication with a document sender (172) that is adapted to send the national phase entry message to the patent office and the instructing message to the prosecuting attorney firm thereby lodging the PCT national phase application.
Patent NZ-528675-A (NZ)
Title: Use of EPO to reduce chemotherapy-induced toxicity in a subject being administered a cytotoxic agent
Inventor: SIGOUNAS GEORGE
IPC: A61P25/00
Filed: 2002-04-08
Abstract: Described is a method of reducing organ toxicity in a subject being administered a cytotoxic agent, comprising concurrently administering with the cytotoxic agent erythropoietin (EPO), the EPO being administered in an amount effective to reduce pulmonary toxicity caused by the cytotoxic agent.